Conflux Founders Hold Executive Roles in Hong Kong-listed Biotech Firm

According to Odaily, public records reveal that Conflux founders Long Fan and Wu Ming serve as executive directors at the Hong Kong-listed company, Leading Pharma Biotech. The current total market value of Leading Pharma Biotech is 371 million Hong Kong dollars, approximately 47.26 million U.S. dollars. Meanwhile, the total market capitalization of Conflux (CFX) tokens stands at 393 million U.S. dollars, ranking 138th in the cryptocurrency market capitalization list.